Related Experiment Video
Updated: Sep 23, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Peripapillary choroidal atrophy in sympathetic ophthalmia and management with triple-agent immunosuppression
Sudha K Ganesh1, Kannan M Narayana, Jyotirmay Biswas
1Uvea Service, Sankara Nethralaya, Medical Research Foundation, Chennai, India. mrf@sankaranethralaya.org
Purpose:
To describe the occurrence of peripapillary choroidal atrophy and experience with triple-agent immunosuppression in three cases of sympathetic ophthalmia.
Materials And Methods:
Retrospective chart review of three cases of sympathetic ophthalmia with peripapillary choroidal atrophy.
Results:
Three patients with sympathetic ophthalmia were managed with steroid pulse therapy and triple-agent immunosuppression. All three patients subsequently developed peripapillary choroidal atrophy.
Conclusions:
Peripapillary choroidal atrophy can occur in sympathetic ophthalmia and may indicate a severe form of inflammation which would benefit from triple-agent immunosuppression.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview